The World Health Organization has temporarily paused the use of anti-malaria drug hydroxychloroquine as part of a global effort to find a cure for Covid-19.
The organisation’s executive board made the decision following a study published in the medical journal The Lancet on 20 May that showed that the drug increased mortality rates among Covid-19 patients.
“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the solidarity trial while the safety data is reviewed by the data safety monitoring board,” the head of the WHO Dr Tedros Ghebreyesus told journalists in a virtual press briefing.
He said the other arms of the trial were continuing.
Hydroxycholoroquine has been touted by US President Donald Trump and other leaders as a possible treatment for Covid-19.
more recommended stories
Former United States president Bill Clinton hospitalized
Former United States President Bill Clinton.
U.K. Former Health Secretary Handed Africa Role After Covid Failings
UK former health secretary Matt Hancock,.
North Korea’s Kim Jong Un, says United States is ‘root cause’ of tensions
North Korean leader Kim Jong has.
Taliban will be judged on their actions, not just their words, says US after talks
THE United States said on Sunday.
At least 50 people killed by a suicide attack on a mosque in Afghanistan
A suicide bomb attack on a.
Donald Trump invokes executive privilege in Move to stifle investigation
Donald Trump intends to assert executive.
Germany puts 100-year-old on trial for Nazi crimes
A 100-year-old former concentration camp guard.
At least 23 people have died after a strong earthquake hit Pakistan
A powerful earthquake collapsed at least.